DocGo Signs CEO Transition Deal: Bienstock Stays Through March 2027, $785,000 Severance
DCGO is trading near its 52-week low of $0.207 (0.8% below the low).
Summary
DocGo locked in CEO Lee Bienstock through March 31, 2027 under a transition agreement paying him $90,000 a month plus $785,000 in severance, while it searches for a successor. The handoff overlaps a Nasdaq bid-price deadline of January 25, 2027 and a going-concern warning.
Key Events · Executive and Board Changes · DCGO
-
CEO Transition Agreement Signed
DocGo and CEO Lee Bienstock entered a Transition Services and Separation Agreement on November 13, 2026; his employment ends March 31, 2027 unless extended, and he moves to senior advisor once a successor CEO starts.
-
Transition Pay and Severance Terms
Bienstock earns $90,000 per month from January 1 through March 31, 2027 and receives a $785,000 severance payment over the 12 months after the transition, or a lump sum if a specified performance target is met; full payment is due no later than March 15, 2028.
-
Equity Vesting and 2026 Bonus
One-sixth of his 2027-vesting equity awards vest on January 31, February 28 and March 31, 2027, and a non-discretionary 2026 bonus is payable by March 15, 2027; unvested awards are forfeited at separation.
-
Change-in-Control Rights Preserved
The agreement expressly keeps his change-in-control rights under section 4.1(b) of the Employment Agreement and the 2021 Stock Incentive Plan, including extra consideration if a change in control occurs within three months after separation.
Analysis · DCGO · Energy & Transportation
DocGo's CEO search now has a hard timeline. Lee Bienstock's employment agreement expires December 31, 2026, and the new Transition Agreement keeps him as CEO through that date, then as CEO/senior advisor from January 1 to March 31, 2027 at $90,000 a month while a successor is found. He gets $785,000 in severance paid over 12 months after the transition, or in a lump sum if a specified performance target is hit, plus a non-discretionary 2026 bonus by March 15, 2027 and COBRA coverage through December 31, 2027. The cost is modest against the company's problems, but leadership continuity matters here: DocGo is trading near its 52-week low, carries a going-concern warning softened by the $102M Perceptive credit facility, and faces a Nasdaq bid-price deadline of January 25, 2027. A CEO exit landing in the same quarter as that listing deadline leaves the turnaround in the hands of an interim arrangement.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DCGO was trading at $0.21 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $20.6M. The 52-week trading range was $0.21 to $1.10. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.